Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today announced the pricing of an underwritten ...

Closing of the private placement and the debt settlement is subject to customary closing conditions and the Company intends to close as soon as practicable. All of the securities will be subject to a ...

Wherley brings nearly a decade of executive leadership at VITAS to his new role. He has served as chief operating officer for the past eight years and assumed the role of president in 2024, overseeing ...

Lytus Fintech, a business unit of Lytus Technologies Holdings PTV Ltd. (OTCMKTS: LYTHF) today announced the launch of its integration and support of XRP with its flagship digital wallet platform NexFi ...

CrazyBulk has long been recognized as a leader in natural, legal performance supplements. In 2025, the brand has solidified ...

Participants may access the live webcast on the Codexis Investor Relations website, where it will be archived for 90 days. The live call can be accessed by dialing 877-705-2976 (domestic) or ...

ORANGE, Calif., July 30, 2025 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC), today reported financial results for its second quarter ended June 30, 2025.

With its combination of expert care, affordable pricing, and the allure of a vibrant cultural experience, Mexico continues to ...

Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical;” the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion ® and the AYON Body ...

Craig-Hallum Capital Group LLC is acting as the sole managing underwriter for the offering. Dyadic intends to use the net proceeds from the proposed offering for working capital and general corporate ...

NASHVILLE, Tenn., July 30, 2025 (GLOBE NEWSWIRE) -- Insight Molecular Diagnostics, or iMDx, (Nasdaq: IMDX), today announced two favorable oral abstracts, including one late-breaking, that will be ...

MARIETTA, Ga., July 30, 2025 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), today announced operating and financial results for the second quarter 2025.